205 Users Online
Antibody Validation Market Segmented By validation methods that is Basic Validation, Genetic Validation, Tagged Protein Validation with product type that is Reagents, Primary Instruments and Consumables
Antibodies produced commercially are of paramount importance in research and development field. Their applications are wide ranging from drug discovery and therapeutics to developing diagnostic kits. However, in recent times it has been observed that the quality of the synthetically produced antibody is not up to the mark which results in inaccurate experimental results.
Antibody validation thus as defined by FDA is the process of validating, using specific laboratory investigations, that the performance characteristics of an investigative method are appropriate for its proposed analytical use.
COVID-19 pandemic is expected to affect the global market of antibody validation by causing disruptions in supply chain which in this case are already opaque enough to cause problems the uncertainty in the market due to irregular lockdowns is going to add to the list of challenges existing for the antibody validation market.
One of the major drivers for the antibody validation market would be increasing realization among the researchers about the inconsistent quality of antibodies. Extensive use of antibody by researchers for the therapeutics and diagnosis will keep the demand for antibodies high which in turn would result in growth of the antibody validation market.
The entry barriers have not been stringent for commercial production of antibodies leading to degraded quality of products. This market flooding by low quality antibodies will lead to growth in the market of antibody validation to ensure good quality products.
Setting up of groups like International Working Group on Antibody Validation (IWGAV), will boost the global market for antibody validation as there will be a dedicated forum for issuing guidelines and discussing the problems. The major barriers for the global market of antibody validation are opaque supply chains and not well accepted, industry-wide quality standards for antibodies.
Another pull factor for the antibody validation market could be the cost associated with antibody validation which adds to the manufacturing cost of the antibody. Since the cost of antibody validation constitutes the major developmental cost, it is not encouraged by the manufacturing firms.
Lack of streamlined supply chain where the reagent should pass through an organisation for antibody validation could be another important reason for the lack of growth of antibody validation market. No set rules as to whether the reagent falls in which category quality wise could add to the list of factors affecting the growth of antibody validation market negatively.
|Based on validation methods
|Based on product type
The antibody validation market is expected to register a robust growth owing to the increased awareness about the quality of antibodies. The overall antibody market is set to register a positive growth which will in turn register steady growth for the global market of antibody validation.
Based on product type reagents and consumable can be expected to register positive growth owing to their more use compared to primary instrument.
North America can be estimated to be the most lucrative market in the global antibody validation market since the maximum research and development projects in the life sciences are taking place in the region. Second lucrative market in the global antibody validation market can be expected to be Europe as it has next most number of research projects requiring use of antibodies.
South Asia, East Asia will be attractive in the emerging market segment of antibody validation market owing to the greater number of research collaborations among various institutes in the region. Middle East and Africa can be estimated to be the least attractive in the global antibody validation market owing to the limited financial and infrastructure capabilities.
The key market players active in the global antibody validation market are OriGene, LifeSpan Biosciences, Rockland antibodies and assays, Badrilla among others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.